Adragos Pharma
Maisons-Alfort, France adragos-pharma.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Adragos Pharma is a global CDMO headquartered in Munich, Germany, serving pharmaceutical and biotech clients in Europe, Japan, and North America. It provides development and manufacturing services for drug products across small molecules and large molecules, with sites in Greece, Switzerland, Japan, France, and Germany.
Services
Drug Development
Provides customised development services including out-licensing, supply, one-off analysis, custom developments, and advanced formulation services.
Formulation Development
Develops formulations in a GMP-like R&D environment designed to support scale-up to manufacturing sites.
Analytical Development
Offers analytical support for development projects, including GMP analytical testing at the Athens site.
Clinical Development
Supports clinical-stage projects through feasibility studies and pre-clinical material preparation to GMP-compliant production.
Expertise in HPAPI
Handles highly potent active pharmaceutical ingredients in a dedicated Athens laboratory and development suite.
Clinical Manufacturing
Guides projects through clinical manufacturing, from feasibility and pre-clinical material preparation to GMP-compliant production.
Preclinical Material
Prepares pre-clinical material as part of the clinical manufacturing workflow.
Clinical Supply
Provides supply services as part of the full development-to-trial-supply chain.
11 more services
- Aseptic Filling
- Lyophilisation
- Commercial Manufacturing
- Visual Inspection
- Pharmaceutical Packaging
- Controlled Drugs
- Supply Chain Planning
- Drug Stability Testing
- Cold Chain Management
- Regulatory Services
- Out Licensing
Capabilities
- Assays and studies
- Stability studies
- Analytical development
- Lyophilization
- Small molecules
- Antibodies
- Fill-finish
9 more
- One-off analysis
- Method establishment
- Raw material testing
- In-process chemistry testing
- API release testing
- Drug product release testing
- ICH stability testing
- Comparator testing
- Visual inspection
- Scale and capacity
- More than 3,000 sqm of R&D facilities in Athens
- More than 60 scientists in Athens
- Inspection of 30 million ampoules per year
- Inspection of 2 billion tablets per year
- 2 aseptic filling lines dedicated to PFS
- Filling speed up to 540 syringes/min
5 more
- Capacity support up to 150 million units/year
- 1 aseptic filling line and 2 large freeze dryers
- Annual capacity up to 6 million vials/year
- Freeze-drying up to 70,000 vials
- Crimping up to 350 vials/min
- Therapeutic areas
- Infertility treatment
- Cancer
Instruments and platforms
- CIP/SIP
- RABS
Modalities and species
- Modalities
- Small molecule
- Antibody
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: Maisons-Alfort manufacturing site
Company
- Type
- CDMO
- Founded
- 2023
- Team
- More than 60 scientists in Athens
Locations
- Based in
- Maisons-Alfort, France
- Sites
- Munich, Germany
- Athens, Greece
- Jura, Switzerland
- Kawagoe, Japan
- Livron-sur-Drôme, France
- Leipzig, Germany
- Tokyo, Japan
- Serves
- Europe, Japan, North America, U.S., EU
Public records
- Parent company
- Adragos Pharma GmbH · DE GLEIF